PAVmed Inc.
PAVM
$0.72
-$0.04-5.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -99.05% | 25.92% | 489.76% | 126.46% | 836.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.05% | 25.92% | 489.76% | 126.46% | 836.61% |
| Cost of Revenue | -97.02% | -22.37% | -1.13% | 29.57% | -0.43% |
| Gross Profit | 93.24% | 61.03% | 54.77% | 18.44% | 62.68% |
| SG&A Expenses | -62.96% | -12.00% | 2.37% | -26.48% | -26.35% |
| Depreciation & Amortization | -100.00% | -83.76% | -79.21% | -26.34% | -0.20% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -70.19% | -22.95% | -11.93% | -27.83% | -29.46% |
| Operating Income | 68.34% | 25.44% | 16.99% | 31.20% | 33.41% |
| Income Before Tax | 106.56% | 379.13% | 16.64% | 16.67% | 29.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 106.56% | 379.13% | 16.64% | 16.67% | 29.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -91.43% | -9.59% | 21.82% | -22.95% | -18.00% |
| Net Income | 110.20% | 464.43% | 25.52% | 15.16% | 31.40% |
| EBIT | 68.34% | 25.44% | 16.99% | 31.20% | 33.41% |
| EBITDA | 67.31% | 23.35% | 14.98% | 31.64% | 34.42% |
| EPS Basic | 106.27% | 370.29% | 43.26% | 5.78% | 40.05% |
| Normalized Basic EPS | 95.61% | 59.53% | 53.20% | 56.22% | 27.36% |
| EPS Diluted | 99.38% | 160.53% | 43.26% | 5.78% | 40.05% |
| Normalized Diluted EPS | 99.64% | 90.90% | 53.20% | 56.22% | 27.36% |
| Average Basic Shares Outstanding | 34.96% | 34.07% | 31.57% | 34.33% | 29.22% |
| Average Diluted Shares Outstanding | 1,544.77% | 495.96% | 31.57% | 34.33% | 29.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |